Trial Profile
Effects of belatacept-based ISR in lung transplantation recipients after CNI failure: A retrospective case series study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2017
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 25 Sep 2017 New trial record